Antengene To Present One Oral and Four Abstracts at ASCO 2024
/PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated...
Source: prnewswire.com
Peter Qian News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Peter Qian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Peter Qian Today - Breaking & Trending Today
Antengene Presents Encouraging Clinical Data from Four Pipeline Programs at the 2023 R&D Day
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to...
Source: prnewswire.com
Antengene to Host 2023 R&D Day and Discuss Key Data with KOLs
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to...
Source: prnewswire.com
Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to...
Source: prnewswire.com
Antengene Announces Interim Financial Results for 2023 with New Clinical Data Highlighting the Growing Value of Its Pipeline
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), today announced its interim results for the six-months ended June 30, 2023, and...
Source: prnewswire.com